Search results for " Colitis."

showing 10 items of 292 documents

Ménétrier's disease in a patient with refractory ulcerative colitis: a clinical challenge and review of the literature

2023

Ménétrier’s disease (MD) is a rare disease of the stomach, characterised by hypertrophic gastric folds leading to protein loss. The association with ulcerative colitis (UC) is rare but has been reported in the literature. We report a case of a 29-year-old male affected by UC with an additional diagnosis of MD 3 years after UC diagnosis. UC was refractory to several treatment lines (thiopurines, infliximab, vedolizumab and ustekinumab), and the patient underwent colectomy. Octreotide was administered for MD normalising blood biochemistry, but it was not effective in inducing endoscopic remission of the stomach. Treatment options in patients with MD and UC are discussed.

AdultMalemedicine.medical_specialtymedicine.medical_treatmentGastroenterologyInflammatory bowel diseaseVedolizumabInternal medicineUstekinumabmedicineHumansGastritis HypertrophicColectomybusiness.industryGeneral Medicinemedicine.diseaseUlcerative colitisInfliximabInfliximabMénétrier's diseaseColitis UlcerativeUstekinumabbusinessRare diseasemedicine.drugdrugs: gastrointestinal system; gastroenterology; inflammatory bowel disease
researchProduct

Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gaps.

2015

Abstract Background and purpose Information received by IBD patients about their disease is of particular importance. The objective of the study was to determine the information resources these patients used, together with their perceived information gaps and expected preferences. Patients and methods A prospective, observational, cross-sectional study conducted on IBD patients attending 13 Spanish hospitals during 2008. Patients completed a semi-structured 52-question survey. Results Survey was adequately completed by 379 of 385 patients (98%), of whom 57% had Crohn's disease and 43% ulcerative colitis. Mean patient age was 37.9 years (range, 16–76 years). Gastroenterologists were the most…

Adultmedicine.medical_specialtyAdolescentGeneral PracticeInformation Seeking BehaviorInformation needsDiseaseInflammatory bowel diseaseNurse's RoleYoung AdultPatient Education as TopicPatient ageSurveys and QuestionnairesmedicineHumansProspective StudiesPhysician's RoleAgedInternetHepatologybusiness.industryGastroenterologyMiddle Agedmedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisSurgerySelf-Help GroupsCross-Sectional StudiesPatient SatisfactionFamily medicineObservational studybusinessGastroenterologia y hepatologia
researchProduct

Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis.

2003

Timely diagnosis of intraepithelial neoplasias (IN) and colitis-associated colon carcinomas (CRC) is crucially important for the treatment of ulcerative colitis (UC). We performed a randomized, controlled trial to test whether chromoendoscopy (CE) might facilitate early detection of IN and CRC in UC.A total of 263 patients with long-standing UC (or=8 years) were screened for potential inclusion in the study, 165 of whom were randomized at a 1:1 ratio to undergo conventional colonoscopy or colonoscopy with CE using 0.1% methylene blue. Five mucosal biopsy specimens were taken every 10 cm between the rectum and cecum. Circumscript lesions in the colon were evaluated according to a modified pi…

Adultmedicine.medical_specialtyColorectal cancerBiopsyRectumColonoscopyPilot ProjectsGastroenterologySeverity of Illness IndexChromoendoscopyPredictive Value of TestsInternal medicineBiopsymedicineHumansProspective StudiesColitisColoring AgentsAgedIntraepithelial neoplasiaHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyColonoscopyMiddle Agedmedicine.diseaseUlcerative colitisMethylene Bluemedicine.anatomical_structureColonic NeoplasmsColitis UlcerativebusinessCarcinoma in SituGastroenterology
researchProduct

Chromoscopy-Guided Endomicroscopy Increases the Diagnostic Yield of Intraepithelial Neoplasia in Ulcerative Colitis

2007

Background & Aims: Because of the large number of biopsy specimens, surveillance colonoscopy in ulcerative colitis (UC) is currently time consuming and significant flat lesions still may be missed. In this study we assessed the value of combined chromoscopy and endomicroscopy for the diagnosis of intraepithelial neoplasias in a randomized controlled trial. Methods: A total of 161 patients with long-term UC in clinical remission were randomized at a 1:1 ratio to undergo conventional colonoscopy or chromoscopy with endomicroscopy. Eight patients were excluded because of insufficient bowel preparation. In the conventional colonoscopic group (n = 73), random biopsy examinations and targeted bio…

Adultmedicine.medical_specialtyTime FactorsColonBiopsyVideo RecordingSensitivity and SpecificitySeverity of Illness IndexTargeted biopsyGastroenterologyChromoendoscopyPredictive Value of TestsInternal medicineBiopsyEndomicroscopyHumansMedicineIntestinal MucosaColitisColoring AgentsAgedFluorescent DyesIntraepithelial neoplasiaMicroscopy ConfocalHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyColonoscopyMiddle Agedmedicine.diseaseUlcerative colitisMethylene BluePredictive value of testsColonic NeoplasmsColitis UlcerativeFluoresceinRadiologybusinessCarcinoma in SituGastroenterology
researchProduct

Auto-immune haemolytic anaemia in ulcerative colitis: report of three cases.

1994

Autoimmune diseaseHemolytic anemiaAdultMalebusiness.industryHematologyGeneral Medicinemedicine.diseaseAuto immuneUlcerative colitisAdrenal Cortex HormonesImmunopathologyImmunologymedicineSplenectomyHumansColitis UlcerativeFemaleAnemia Hemolytic AutoimmuneYoung adultComplicationbusinessColectomyImmunosuppressive AgentsActa haematologica
researchProduct

Clostridium difficile Toxins Disrupt Epithelial Barrier Function by Altering Membrane Microdomain Localization of Tight Junction Proteins

2001

ABSTRACT The anaerobic bacterium Clostridium difficile is the etiologic agent of pseudomembranous colitis. C. difficile toxins TcdA and TcdB are UDP-glucosyltransferases that monoglucosylate and thereby inactivate the Rho family of GTPases (W. P. Ciesla, Jr., and D. A. Bobak, J. Biol. Chem. 273:16021–16026, 1998). We utilized purified reference toxins of C. difficile , TcdA-10463 (TcdA) and TcdB-10463 (TcdB), and a model intestinal epithelial cell line to characterize their influence on tight-junction (TJ) organization and hence to analyze the mechanisms by which they contribute to the enhanced paracellular permeability and disease pathophysiology of pseudomembranous colitis. The increase i…

Bacterial ToxinsImmunologyClostridium difficile toxin ABiologyZonula Occludens-2 ProteinOccludinMicrobiologyCell junctionPermeabilityTight JunctionsMicrobiologyAdherens junctionEnterotoxinsMembrane MicrodomainsBacterial ProteinsIntestinal MucosaClostridioides difficileCell PolarityMembrane ProteinsPseudomembranous colitisClostridium difficilePhosphoproteinsMolecular PathogenesisActinsCell biologyInfectious DiseasesMembrane proteinGlucosyltransferasesParacellular transportZonula Occludens-1 ProteinParasitologyInfection and Immunity
researchProduct

Analysis of the Association between Fatigue and the Plasma Lipidomic Profile of Inflammatory Bowel Disease Patients

2020

Inflammatory bowel disease (IBD) is a chronic, relapsing noninfectious inflammatory condition of the intestinal tract with two main phenotypes, ulcerative colitis (UC) and Crohn's disease (CD), and globally increasing incidence and prevalence. Nearly 80% of the IBD patients with active disease and 50% of those with inactive disease suffer fatigue with significant impairment of their quality of life. Fatigue has been associated with multiple factors in IBD patients but, in most cases, no direct cause can be identified, and risk factors in clinically quiescent IBD are contradictory. Furthermore, as the assessment of fatigue is subjective, there is an unmet clinical need for fatigue biomarkers…

BioquímicaBiologiamedicine.medical_specialtyDiseaseBiochemistryInflammatory bowel diseaseGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineLipidomicsmedicineHumansFatigue030304 developmental biology0303 health sciencesCrohn's diseasebusiness.industryIncidence (epidemiology)General ChemistryInflammatory Bowel Diseasesmedicine.diseaseSphingolipidUlcerative colitis3. Good health030220 oncology & carcinogenesisLipidomicsQuality of LifeColitis UlcerativebusinessSphingomyelinJournal of Proteome Research
researchProduct

Bone loss in inflammatory Bowel disease: our multicentric study

2011

Patients with inflammatory bowel disease are at increased risk of developing disorder in bone and mineral metabolism The study was aimed to determine if inflammatory bowel disease (IBD) is a risk factor for osteoporosis in 103 adult patients. We included 103 IBD patients, 67 patients with Crohn’s disease (CD) and 36 with ulcerative colitis (UC). Bone mineral density was measured by dual-energy X-ray absorptiometry. We used T score to express bone loss (osteopenia: -2.5 SD 2 years) and active disease would be risk factors of bone mineral loss in IBD.

Bone mineralmedicine.medical_specialtybusiness.industryOsteoporosisDiseasemedicine.diseaseGastroenterologyUlcerative colitisInflammatory bowel diseasedigestive system diseasesOsteopeniaIncreased riskInternal medicinemedicineRisk factorbusinessEndocrinology Studies
researchProduct

Budesonide MMX and mesalamine to induce remission in patients with ulcerative colitis

2013

Budesonidemedicine.medical_specialtySettore MED/09 - Medicina InternaHepatologybusiness.industryGastroenterologymedicine.diseaseUlcerative colitisGastroenterologyInternal medicineMedicineIn patientColitisbusinessbudesonide MMX.ulcerative colitismedicine.drugMMX
researchProduct

Pyostomatitis vegetans und Morbus Crohn: Eine spezifische Assoziation zweier Krankheiten

2008

HISTORY AND CLINICAL FINDINGS A 27-year-old man was referred to the dermatological out-patient clinic because of inflammatory changes in the oral mucosa of unknown cause. 5 months earlier he had been diagnosed as having Crohn's disease of the terminal ileum. On both sides of the buccal mucosa there were rough erythematous vegetations and disseminated miliary abscesses, which extended to the labial gingiva and the soft palate. Further physical examination was unremarkable. INVESTIGATIONS Several inflammatory parameters were increased: C-reactive protein 100 mg/l, erythrocyte sedimentation rate 55/88 mm, eosinophilic cationic protein 35.8 ng/ml (normal range 2.3-16 ng/ml). White cell count wa…

Budesonidemedicine.medical_specialtymedicine.diagnostic_testbusiness.industryGeneral Medicinemedicine.diseaseUlcerative colitisGastroenterologymedicine.anatomical_structureGastrointestinal diseaseErythrocyte sedimentation rateInternal medicineBiopsymedicineEosinophiliamedicine.symptomOral mucosabusinessPyostomatitis vegetansmedicine.drugDMW - Deutsche Medizinische Wochenschrift
researchProduct